HEALTH GAP VENTURES

A market gap that matters

HGV funds companies that close health inequities. Founders solving these problems need mission-aligned capital — investors who understand the complexities of underserved markets and treat them as opportunities, not afterthoughts. Today, most healthcare venture investors systematically underweight them.​

The status quo widens the gap.
​Healthcare venture capital claims to fund products and services that improve health for everyone. In practice, the vast majority of investors overlook how race, socioeconomic status, gender, and ability shape health outcomes — and that blind spot widens the gap it should be closing.

​

Bias shapes what gets funded.
​Investor bias against underserved populations distorts deal flow. Companies serving these markets see less capital, less attention, and fewer term sheets — regardless of their potential to deliver both returns and impact.

​

We see a segment others miss.

By focusing exclusively on the health gap, HGV backs high-potential companies the rest of the market overlooks — and turns an ignored segment into a source of transformative impact.